MANNKIND

Monomeric insulin administered by oral inhalation enables ultra-rapid delivery, with time to appearance in systemic circulation of <1 minute 1,3... Afrezza is absorbed through the lungs without having to change molecular structure, pass through SC tissue, or undergo first-pass metabolism, thereby facilitating ultra-rapid onset (i.e., time to reach peak effect) 1-3... Afrezza achieves blood insulin concentrations within 12 minutes and produces maximal glucose lowering in about 45 minutes with a short duration of action (about 3 hours) 1,9

Also known as: MannKind Corporation